X27339B
Dilation Pulmonary Artery, Right to New Technology Group 11 with Intraluminal Device, Expandable, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | 7 Dilation |
| Body Part | 3 Pulmonary Artery, Right |
| Approach | 3 Percutaneous |
| Device | 9 Intraluminal Device, Expandable |
| Qualifier | B New Technology Group 11 |
Operation Definition
Expanding an orifice or the lumen of a tubular body part
Procedure Overview
This family describes catheter-based procedures that widen a narrowed or blocked blood vessel using next-generation devices, most notably bioresorbable vascular scaffolds that prop the artery open and then gradually dissolve over months rather than remaining as permanent metal, the way a conventional stent does. Patients typically undergo this when a coronary artery has narrowed enough to restrict blood flow to the heart muscle, causing chest pain or increasing the risk of a heart attack.
The appeal of the newer scaffold technology is that once the vessel has healed and remodeled around it, no permanent foreign material remains, which proponents argue may allow the artery to regain more of its natural flexibility and reduce certain long-term complications tied to permanently implanted hardware.
Anatomy & Axis Detail
Pulmonary Artery, Right
The right pulmonary artery carries deoxygenated blood to the right lung, and dilation of this vessel is performed when it becomes narrowed, most often as a residual or recurrent stenosis following surgical repair of congenital heart defects such as tetralogy of Fallot or after prior pulmonary artery banding. Balloon dilation, sometimes combined with a specialized new-technology device or drug-coated balloon, restores luminal diameter and reduces the right ventricular pressure overload that results from downstream obstruction. Because branch pulmonary artery stenosis can be diffuse or involve multiple segments, the procedure is often performed under fluoroscopic guidance with careful pressure gradient measurement across the lesion before and after treatment, and documentation should specify the device technology and confirm the right-sided branch as the treated vessel, distinguishing it from the main pulmonary trunk or the left branch.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intraluminal Device, Expandable
This value identifies an intraluminal device built to expand once deployed within a body lumen, enlarging the internal diameter to restore or maintain patency. It differs from temporary or non-expandable intraluminal devices coded elsewhere in this axis by its mechanism of mechanically widening the vessel or duct after placement. The distinction matters because expandable designs are typically left in place permanently, unlike removable temporary devices.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Correct code assignment depends on documentation identifying the specific scaffold or device material, the number of sites or vessels treated, and confirmation that the device qualifies under the applicable New Technology Approval Group rather than being a standard drug-eluting stent. A frequent error is undercounting the number of intraluminal devices deployed, or coding a bioresorbable scaffold placement under the standard Medical and Surgical dilation table simply because the physician's note used generic language like "stent" without specifying the technology.
Commonly Confused With
This family is easily confused with the standard Medical and Surgical coronary artery dilation table, since both describe widening a vessel with a catheter-delivered device. The distinguishing detail is the device itself, a scaffold formally recognized under New Technology criteria versus a conventional metal or drug-eluting stent, so the operative documentation of device type is what separates the two.